IBIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.76 USD | +2.33% |
|
+2.33% | +28.47% |
Valuation
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 14.35 | 13.95 | 262.8 | 329 | 57.6 | 10.25 |
| Enterprise Value (EV) 1 | 23.49 | 34.41 | 240.6 | 264.7 | 51.87 | 23.42 |
| P/E ratio | -0.58 x | -0.75 x | -3.64 x | -12.6 x | -1.14 x | -0.11 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 32.3 x | 6.91 x | 160 x | 139 x | 24.2 x | - |
| EV / Revenue | 52.9 x | 17.1 x | 147 x | 112 x | 21.8 x | - |
| EV / EBITDA | -1.88 x | -2.48 x | -20.5 x | -9.27 x | -1.12 x | -0.84 x |
| EV / FCF | -2.75 x | -4.01 x | -17.6 x | -12 x | -1.41 x | -0.79 x |
| FCF Yield | -36.4% | -24.9% | -5.67% | -8.32% | -70.9% | -126% |
| Price to Book | 0.89 x | 5.79 x | 5.49 x | 3.03 x | 0.91 x | 0.81 x |
| Nbr of stocks (in thousands) | 31.9 | 39.4 | 237 | 436 | 436 | 840 |
| Reference price 2 | 450.0 | 354.0 | 1,110 | 755.0 | 132.0 | 12.20 |
| Announcement Date | 9/18/18 | 8/26/19 | 10/13/20 | 9/28/21 | 10/11/22 | 9/27/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.444 | 2.018 | 1.638 | 2.371 | 2.383 | - |
| EBITDA 1 | -12.52 | -13.86 | -11.76 | -28.55 | -46.42 | -28.05 |
| EBIT 1 | -14.23 | -15.61 | -14 | -30.97 | -49.69 | -28.78 |
| Operating Margin | -3,204.28% | -773.49% | -854.88% | -1,306.12% | -2,085.19% | - |
| Earnings before Tax (EBT) 1 | -16.11 | -17.6 | -16.44 | -23.21 | -50.3 | -29.31 |
| Net income 1 | -16.1 | -17.59 | -16.44 | -23.21 | -50.3 | -65.01 |
| Net margin | -3,627.25% | -871.8% | -1,003.6% | -978.79% | -2,110.91% | - |
| EPS 2 | -769.7 | -471.7 | -304.6 | -59.98 | -115.6 | -106.2 |
| Free Cash Flow 1 | -8.548 | -8.572 | -13.64 | -22.03 | -36.77 | -29.52 |
| FCF margin | -1,925.17% | -424.78% | -832.61% | -929.3% | -1,543% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 9/18/18 | 8/26/19 | 10/13/20 | 9/28/21 | 10/11/22 | 9/27/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: Juni | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q2 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.211 | 0.168 | 1.943 | 0.061 | - | 0.13 | 0.205 | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - |
| EBIT | -8.974 | -11.64 | -12.18 | -16.9 | -7.636 | -10.57 | - | - | - |
| Operating Margin | -4,253.08% | -6,927.38% | -626.97% | -27,698.36% | - | -8,133.08% | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - |
| Net income | - | -11.94 | - | - | - | - | - | - | - |
| Net margin | - | -7,108.33% | - | - | - | - | - | - | - |
| EPS 2 | - | -25.00 | -30.00 | -112.6 | -41.00 | - | - | - | -4.420 |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/15/21 | 2/14/22 | 5/12/22 | 10/11/22 | 11/14/22 | 2/14/23 | 5/15/23 | 9/27/23 | 2/15/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: Juni | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 9.15 | 20.5 | - | - | - | 13.2 |
| Net Cash position 1 | - | - | 22.2 | 64.3 | 5.73 | - |
| Leverage (Debt/EBITDA) | -0.7307 x | -1.476 x | - | - | - | -0.4697 x |
| Free Cash Flow 1 | -8.55 | -8.57 | -13.6 | -22 | -36.8 | -29.5 |
| ROE (net income / shareholders' equity) | -128% | -189% | -55.7% | -28.1% | -58.5% | -74.3% |
| ROA (Net income/ Total Assets) | -22.5% | -26.5% | -14% | -16.1% | -25.2% | -25.6% |
| Assets 1 | 71.63 | 66.43 | 117.2 | 144.6 | 199.5 | 254.1 |
| Book Value Per Share 2 | 504.0 | 61.10 | 202.0 | 249.0 | 145.0 | 15.10 |
| Cash Flow per Share 2 | 497.0 | 110.0 | 197.0 | 178.0 | 52.00 | 4.240 |
| Capex 1 | 0.93 | 0.92 | 1.08 | 4.92 | 7.33 | 6.43 |
| Capex / Sales | 210.36% | 45.59% | 65.81% | 207.51% | 307.6% | - |
| Announcement Date | 9/18/18 | 8/26/19 | 10/13/20 | 9/28/21 | 10/11/22 | 9/27/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +28.47% | 15.16M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- IBIO Stock
- Financials iBio, Inc.
